Uppsala, Sweden – Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of sample preparation products with the launch of EVOLUTE WAX.
EVOLUTE WAX is a mixed-mode weak anion exchanger, developed for the extraction of strongly acidic analytes from aqueous samples. The resin-based sorbent is surface modified with well defined hydroxyl-functional oligomers, imparting excellent water wettability. An optimized combination of non-polar (hydrophobic), polar (hydrophilic) and anion exchange interactions allows efficient extraction of strongly acidic analytes of wide ranging polarities.
Such strongly acidic analytes are typical of organophosphate pesticide metabolites and EVOLUTE WAX provides analytical scientists with the ability to extract such compounds more efficiently from diverse matrices, ranging from ground water to blood. The non-polar/anion exchange dual retention mechanism allows the use of a rigorous interference regime, providing extremely clean extracts and reducing matrix effects associated with LC-MS/MS analysis.
“The addition of EVOLUTE WAX compliments and further increases the application scope of the EVOLUTE family of resin-based, solid-phase extraction products and further demonstrates our commitment to continuous development of high quality solutions for our customers” says Gary Dowthwaite, Product Manager for EVOLUTE product at Biotage.
For more information regarding Biotage sample preparation products, please email email@example.com or visit www.biotage.com/SamplePrep
For further press information at Biotage please contact: Rob Thompson, Director of Marketing Communications, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 Tel: +1 704 654 4847 Fax: +1 704 654 4917 Email: firstname.lastname@example.org
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala with subsidiaries in the US, UK and Japan. Biotage has 272 employees and sales of 428.9 MSEK in 2010. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website:www.biotage.com
Opioids: Choosing the Best Solution for your Laboratory
Notice of Discontinuation of Biotage ZIP® and Biotage ZIP® Sphere
An Environmental Chemist Speaks Out
Drugs of Abuse Urine Testing White Paper Updated to Include a Further 50 Analytes
Application Video 894: Extraction of Aldosterone and Angiotensin from Plasma